Institute for OneWorld Health

PATH
Nonprofit organization
Founded 1977
Headquarters Seattle
Key people
 Steve Davis, president and CEO
Revenue US$330,000,000 (as of 2012)[1]
Number of employees
 1100+
Website http://www.path.org/

OneWorld Health was a 501(c)(3) nonprofit drug development organization founded in San Francisco in 2000 by Victoria Hale.[2] In December 2011, OneWorld Health became a drug development program of PATH (global health organization), an international nonprofit organization that transforms global health through innovation.[3]

PATH’s Drug Development program is working to develop and ensure availability and accessibility of safe and effective new medicines for diseases disproportionately affecting people in resource-limited settings. It works with partners around the globe to identify potential new medicines for diseases affecting vulnerable populations, assess the safety and effectiveness of investigational medicines, honor international ethical standards for research, collaborate to manufacture and distribute new medicines, and ensure that medicines will be affordable and available for distribution.

PATH’s current drug development efforts are focused on targeting diarrheal disease, ensuring the supply of malaria treatments, and developing a new tool to stop the spread of HIV. More information about these efforts is available at the program website.[4]

History

PATH's Drug Development program grew out of an affiliation with OneWorld Health, a nonprofit pharmaceutical organization founded in San Francisco, CA in 2000.

References

  1. ↑ "PATH 2012 Annual Report". path.org. 2013. Retrieved August 28, 2013.
  2. ↑ Elias, Paul (2004-02-09). "Nonprofits Work With Drug Firms to Treat Diseases in Third World". Los Angeles Times. ISSN 0458-3035. Retrieved 2016-05-01.
  3. ↑ "OneWorld Health to become an affiliate of PATH". PATH. Retrieved 8 February 2014.
  4. ↑ PATH drug development program web site

Further reading

External links

This article is issued from Wikipedia - version of the 5/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.